Autoantibodies to cryptic epitopes elicited by infection with lactate dehydrogenase-elevating virus

Scandinavian Journal of Immunology

Volumn 51, Issue 5, 2000, Pages 447-453

  Gomez K A ^a   Coutelier, J P ^b   Mathieu, P A ^a   Lustig, L ^c   Retegui, Lilia A ^a  

^a Instituto de Quimica y Fisicoquimica Biologicas Buenos Aires   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c DE DUVE INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPITOPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; LACTIC DEHYDROGENASE TOGAVIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, VIRAL; ARTERIVIRUS INFECTIONS; AUTOANTIBODIES; BLOTTING, WESTERN; CATTLE; CROSS REACTIONS; EPITOPES, B-LYMPHOCYTE; HYPERGAMMAGLOBULINEMIA; LACTATE DEHYDROGENASE-ELEVATING VIRUS; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; RABBITS; TISSUE EXTRACTS;

EID: 0034055828     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00704.x     Document Type: Article

References (25)

1. 1 Meulenberg JJ, Hulst MM, de Meijer EJ et al. Lelystad virus belongs to a new virus family, comprising lactate dehydrogenase-elevating virus, equine arteritis virus, and simian hemorrhagic fever virus. Arch Virol Suppl 1994;9:441-8.
2. 2 Rowson KEK, Mahy BWJ. Lactate dehydrogenase-elevating virus. J Gen Virol 1985;66:2297-312.
3. 3 Plagemann PGW, Rowland RRR, Even C, Faaberg KS. Lactate dehydrogenase-elevating virus. An ideal persistent virus? Springer Semin Immunopathol 1995;17:167-86.
4. 4 van den Broek MF, Spörri R, Even C, et al. Lactate dehydrogenase-elevating virus (LDV). Lifelong coexistence of virus and LDV-specific immunity. J Immunol 1997;159:1585-8.
5. 5 Coutelier J-P, Coulie PG, Wauters P, Heremans H, van der Logt JTM. In vivo polyclonal B-lymphocyte activation elicited by murine viruses. J Virol 1990;64:5383-8.
6. 6 Coutelier J-P, van der Logt JTM, Heessen FWA, Warnier G, Van Snick J. IgG2a restriction of murine antibodies elicited by viral infections. J Exp Med 1987;165:64-9.
7. 7 Monteyne P, Van Broeck J, Van Snick J, Coutelier J-P. Inhibition by lactate dehydrogenase-elevating virus of 'in vivo' interleukin 4 production during immunization with keyhole limpet haemocyanin. Cytokine 1993;5:394-7.
8. 8 Coutelier J-P, Van Broeck J, Wolf S. Interleukin-12 gene expression after viral infection in the mouse. J Virol 1995;69:1955-8.
9. 9 Verdonck E, Pfau CJ, González M-D, Masson PL, Coutelier J-P. Influence of viral infection on anti-erythrocyte autoantibody response after immunization of mice with rat red blood cell. Autoimmunity 1994;17:73-81.
10. 10 Weiland E, Weiland F, Grossmann A. Lactate dehydrogenase-elevating virus induces anti-Golgi apparatus antibodies. J Gen Virol 1987;68:1983-91.
11. 11 Cafruny WA, Hovinen DE. Infection of mice with lactate dehydrogenase-elevating virus leads to stimulation of autoantibodies. J Gen Virol 1988;69:723-9.
12. 12 Gómez KA, Coutelier J-P, Retegui LA. Changes in the specificity of antibodies in mice infected with lactate dehydrogenase-elevating virus. Scand J Immunol 1997;46:168-74.
13. 13 Mazza MM, Retegui LA. The antigenic topography of human growth hormone. Molec Immunol 1989;26:231-40.
14. 14 Coutelier J-P, van der Logt JTM, Heessen FWA, Warnier G, Van Snick J. Rheumatoid factor production in 129/Sv mice: involvement of an intestinal infectious agent. J Immunol 1986;137:337-40.
15. 15 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with the folin phenol reagent. J Biol Chem 1951; 193:265-75.
16. 16 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
17. 17 Cohen AD, Shoenfeld Y. The viral-autoimmunity relationship. Viral Immunol 1995;8:1-9.
18. 18 Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol 1995;7:812-18.
19. 19 Dighiero G, Rose NR. Critical self-epitopes are key to the understanding of self-tolerance and autoimmunity. Immunol Today 1999;20:423-8.
20. 20 Monteyne P, Renauld J-C, Van Broeck J, Dunne DW, Brombacher F, Coutelier J-P. IL-4-independent regulation of in vivo IL-9 expression. J Immunol 1997;159:2616-23.
21. 21 Sun B, Rizzo LV, Sun S-H, et al. Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T helper-1-like or a T helper-2-like response. J Immunol 1997;159:1004-11.
22. 22 Aichele P, Bachmann MF, Hengartner H, Zinkernagel RM. Immunopathology or organ-specific autoimmunity as a consequence of virus infection. Immunol Rev 1996;152:21-45.
23. 23 Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today 1993;14:203-8.
24. 24 Lanzavecchia A. How can cryptic epitopes trigger autoimmunity? J Exp Med 1995;181:1945-8.
25. 25 Bach J-F. Organ-specific autoimmunity. Immunol Today 1995; 16:353-5.